DermTech Investor Relations Material
Latest events
Q4 2023
DermTech
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from DermTech Inc
Access all reports
Segment Data
Access more data
Revenue by
Business area
Assay Revenue
Contract Revenue
Expenses by
Financials
DermTech, Inc. is a molecular diagnostic company focused on the application of genomics to dermatology. DermTech's pioneering technology focuses on the science of processing and decoding the information contained in skin's DNA for healthcare providers. DermTech, Inc. is headquartered in La Jolla, California.
Latest articles
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
)
Moncler: From the Mountains to the Runway
The story of Moncler, all the way from its beginnings in the Alps to its journey to some of the most prestigious runways in the world.
16 Apr 2025
Ticker symbol
DMTK
Country
🇺🇸 United States